课题基金 / 基金详情

UDALL PARKINSON?S DISEASE CENTER AT EMORY UNIVERSITY: CIRCUITRY TO THERAPY

UDALL PARKINSON?S DISEASE CENTER AT EMORY UNIVERSITY: CIRCUITRY TO THERAPY
埃默里大学 UDALL 帕金森病中心:从电路到治疗
批准号:
8357576
负责人:
Thomas N Wichmann
金额:
$4.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2012-04-30

项目摘要

项目成果

Thomas N Wichmann的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. The recently funded Morris K. Udall Parkinson's Disease Center of Excellence at Emory University is a highly collaborative research program in which electrophysiologists, pharmacologists, and anatomists work together to study the effects of existing and new treatments for parkinsonism from a circuit perspective. The center consists of four projects and two cores. Project 1 (Dr. Jaeger) examines changes imposed by altered basal ganglia input onto thalamic neurons in the parkinsonian state. Project 2 (Dr. Wichmann) is a series of experiments in parkinsonian primates to compare the thalamic effects of pallidal and subthalamic nucleus inactivation and stimulation, as are commonly used to treat advanced parkinsonism in patients, with the goal of identifying changes in thalamic activity that are associated with the antiparkinsonian effects of these procedures. Project 3 (Dr. Miller) is a series of translational experiments that examine the use of orally active TrkB receptor agonists as symptomatic or neurorestorative treatment for Parkinson's disease in different rodent and primate models. Project 4 (Dr. Conn, Vanderbilt) investigates the effects of novel subtype-selective muscarinic acetylcholine receptor antagonists and activators on basal ganglia activity, and on parkinsonism in rodent models. The projects are supported by an administrative core (Core A, Dr. Wichmann, PI; Dr. DeLong, Co-I, Dr. Pearson, administrator), and by an anatomy and behavior core (Core B, Dr. Smith) which provides immunohistochemistry and electron microscopy services to all of the center projects, and conducts behavioral testing in MPTP-treated monkeys under project 3.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Morris K. Udall Centers of Excellence for Parkinson's Disease Research at Emory University
  • 批准号:
    10284843
  • 项目类别:
  • 资助金额:
    $239.01万
  • 财政年份:
    2021
  • 负责人:
    Thomas N Wichmann
  • 依托单位:
Morris K. Udall Centers of Excellence for Parkinson's Disease Research at Emory University
  • 批准号:
    10495205
  • 项目类别:
  • 资助金额:
    $235.93万
  • 财政年份:
    2021
  • 负责人:
    Thomas N Wichmann
  • 依托单位:
Administrative Core
  • 批准号:
    10495206
  • 项目类别:
  • 资助金额:
    $20.93万
  • 财政年份:
    2021
  • 负责人:
    Thomas N Wichmann
  • 依托单位:
Administrative Core
  • 批准号:
    10284844
  • 项目类别:
  • 资助金额:
    $20.93万
  • 财政年份:
    2021
  • 负责人:
    Thomas N Wichmann
  • 依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    乔安娜
  • 依托单位: